Cargando…
New drugs and stock market: a machine learning framework for predicting pharma market reaction to clinical trial announcements
Pharmaceutical companies operate in a strictly regulated and highly risky environment in which a single slip can lead to serious financial implications. Accordingly, the announcements of clinical trial results tend to determine the future course of events, hence being closely monitored by the public...
Autores principales: | Budennyy, Semen, Kazakov, Alexey, Kovtun, Elizaveta, Zhukov, Leonid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406841/ https://www.ncbi.nlm.nih.gov/pubmed/37550410 http://dx.doi.org/10.1038/s41598-023-39301-4 |
Ejemplares similares
-
Machine learning-based detection of cardiovascular disease using ECG signals: performance vs. complexity
por: Pham, Huy, et al.
Publicado: (2023) -
An analysis of the stock market reaction to the announcements of the UK Soft Drinks Industry Levy
por: Law, Cherry, et al.
Publicado: (2020) -
Trust and the stock market reaction to lockdown and reopening announcements: A cross-country evidence
por: Xie, Lijuan, et al.
Publicado: (2022) -
Stock Market Reaction to the Announcement of the COVID-19 Lockdown: Evidence from Healthcare Companies in Malaysia
por: Xie, Yi, et al.
Publicado: (2022) -
BigPharma and unethical marketing of medicinal products
por: Myhr, Kirsten
Publicado: (2011)